Tumor Rejection Effects of Allorestricted Tumor Peptide-Specific CD4+ T Cells on Human Cervical Cancer Cell Xenograft in Nude Mice
Authors: Song, Yinhong; Sun, Wei; Weng, Xiufang; Liang, Zhihui; Yu, Qian; Wang, Zhigang; Ouyang, Lichen; Chen, Jun; Wu, Xiaolin; Shen, Guanxin; Wu, Xiongwen
Source: Cell Transplantation, Volume 21, Number 7, July 2012 , pp. 1503-1514(12)
Publisher: Cognizant Communication Corporation
Abstract:Generation of tumor specific alloreactive CD4+ T cells is important to circumvent tumor tolerance. Here, we generate allorestricted peptide-specific CD4+ T cells by coculture of lymphocytes and autologous monocytes bearing allogeneic HLA-DR15 molecule associated with its restricted peptide. Binding of a dimeric HLA-DR15/IgG1-Fc fusion protein (the dimer) to HLA-DR15 negative (HLA-DR15-ve) monocytes made the monocytes coated with the allogeneic epitope. An increased proliferation of CD4+ T cells and induction of Th1 cells appeared after coculturing of HLA-DR15-ve lymphocytes and the autologous monocytes loaded with the dimer. The cocultural bulks showed an increased frequency of the specific dimer-stained CD4+ T cells and the expanded CD4+ T cells exhibited an elevated IFN-γ production in response to specific TCR ligand. Tumor rejection effects of the allorestricted E7-specific CD4+ T cells raised by the coculture were observed in nude mice challenged with human cervical cancer cell SiHa expressing both HLA-DR15 and E7 antigens, as the tumor avoidance and life span of the mice were improved after adoptive transfer of the CD4+ T cells. This study may help to develop strategies to separate graft-versus-leukemia or graft-versus-tumor reaction from graft-versus-host disease, and add to the pool of human high-avidity TCRs specific for tumor or virus antigens.
Document Type: Research Article
Affiliations: Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Publication date: July 1, 2012
- Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
- In this: publication
- By this: publisher
- In this Subject: Anatomy & Physiology , Biology , Biotechnology , Pharmacology , Surgery
- By this author: Song, Yinhong ; Sun, Wei ; Weng, Xiufang ; Liang, Zhihui ; Yu, Qian ; Wang, Zhigang ; Ouyang, Lichen ; Chen, Jun ; Wu, Xiaolin ; Shen, Guanxin ; Wu, Xiongwen